Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood

Hematology

Volumn 10, Issue 5, 2005, Pages 375-378

  Win, N ^a   Madan, B ^b   Gale, R ^c   Matthey, F ^d  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c Pembury Hospital   (United Kingdom)

^d EAST SURREY HOSPITAL   (United Kingdom)

Author keywords

IVIg; Lymphadenopathy; Lymphoma; Recurrent haemolysis

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; ERYTHROCYTE ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN; PREDNISOLONE; STEROID;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD COMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; FEMALE; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; IMMUNOPHENOTYPING; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MANTLE CELL LYMPHOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEMALE; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOMA; MALE; MIDDLE AGED; STEROIDS;

EID: 29144530680     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330500155168     Document Type: Article

References (12)

1. van der Hart M, Engelfriet CP, Prins HK, van Loghem JJ. Haemolytic transfusion reaction without demonstrable antibodies in vitro. Vox Sang 1963;8:363-370.
2. Hedge UM, Gordon-Smith EC, Worlledge SM. Reticulo-cytopenia and absence of red cell auto antibodies in immune haemolytic anaemia. Br Med J 1977;2:1444-1447.
3. Heisto H, Myhre K, Vogt E, Heier AM. Haemolytic transfusion reaction due to incompatibility without demonstrable antibodies. Vox Sang 1960;5:538-544.
4. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction. Transfusion 2001;41: 323-328.
5. Win N, Tullie Y, Needs M, Chen FE, Okpala U. Use of intravenous immunoglobulin and intravenous methylpredni-solone in hyperhaemolysis syndrome in sickle cell disease. Haematology 2004;9:433-436.
6. Treleaven JG, Win N. Hyperhaemolysis syndrome in a patient with myelofibrosis. Haematology 2004;9:147-149.
7. Sokol RJ, Booker DJ, Stamps R, Booth JR, Hook K. IgA red cell autoantibodies and auto-immune hemolysis. Transfusion 1997;37:175-181.
8. Lai M, Rumi C, D'onofrio G, Voso MT, Leone G. Clinically significant auto-immune hemolytic anaemia with a negative direct antiglobulin test by routine tube test and positive by column agglutination method. Immunohematology 2002;18:112.
9. Jasinski M, Pantazopoulos P, Rother RP, van Rooijen N, Song WC, Molina H, Bessler M. A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteins. Blood 2004; 103(7):2827-2834.
10. Packer JT, Greendyke RM, Swisher SN. The inhibition of erythrophagocytosis in vitro by corticosteroids. Transf Assoc Am Physicians 1960;73:93-102.
11. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell haemolytic transfusion reaction syndrome. Transfusion 1997;37:382-392.
12. Rhoades CJ, Williams MA, Kelsey SM, Newland AC. Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin. Blood Rev 2000;14:14-30.